Alcoholism treatment in the United States: An overview

Alcohol Research and Health

Volumn 23, Issue 2, 1999, Pages 69-77

  Fuller, Richard K ^a   Hiller Sturmhöfel, Susanne ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NONE

Author keywords

Addiction care; Aftercare; Alcoholics Anonymous; Behavior therapy; Cognitive therapy; Comparative study; Detoxification; Drug therapy; Inpatient care; Motivational interviewing; Outpatient care; Patients; Treatment outcome; Treatment research; United States

Indexed keywords

DRUGS USED IN THE TREATMENT OF ADDICTION; NALTREXONE; NARCOTIC ANTAGONIST;

ALCOHOLICS ANONYMOUS; ALCOHOLISM; COGNITIVE THERAPY; HUMAN; REVIEW; TREATMENT OUTCOME; UNITED STATES;

ALCOHOL DETERRENTS; ALCOHOLICS ANONYMOUS; ALCOHOLISM; COGNITIVE THERAPY; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; TREATMENT OUTCOME; UNITED STATES;

EID: 0033287368     PISSN: 0090838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. CHICK, J.; GOUGH, K.; FALDOWSKI, W.; KERSHAW, P.; HORE, B.; MEHTA, B.; RITSON, B.; ROPNER, R.; AND TORLEY, D. Disulfiram treatment of alcoholism. British Journal of Psychiatry 161:84-89, 1992.
2. CORNELIUS, J.R.; SALLOUM, I.M.; EHLER J.G.; JARRETT, P.J.; CORNELIUS, M.D.; PEREL, J.M.; THASE, M.E.; AND BLACK, A. Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial. Archives of General Psychiatry 54:700-705, 1997.
3. FINNEY, J.W.; HAHN, A.C.; AND MOOS, R.H. The effectiveness of inpatient and outpatient treatment for alcohol abuse: The need to focus on mediators and moderators of setting effects. Addiction 91:1773-1796, 1996.
4. FLEMING, M.E.; BARRY, K.L.; MANWELL, L.B.; JOHNSON, K.; AND LONDON, R. Brief physician advice for problem alcohol drinkers: A randomized controlled trial in community-based primary care practices. Journal of the American Medical Association 277(13):1039-1045, 1997.
5. FOY, A.; MARCH, S.; AND DRINKWATER, V. Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital. Alcoholism: Clinical and Experimental Research 12:360-364, 1988.
6. FULLER, R.K., AND ROTH, H.P. Disulfiram for the treatment of alcoholism: An evaluation in 128 men. Annals of Internal Medicine 90:901-904, 1979.
7. FULLER, R.K.; BRANCHEY, L.; BRIGHTWELL, D.R.; DERMAN, R.M.; EMRICK, C.D.; IBER, F.L.; JAMES, K.E.; LACOURSIERE, R.B.; LEE, K.L.; LOWENSTAM, I.; MAANY, I.; NEIDERHISER, D.; NOCKS, J.J.; AND SHAW, S. Disulfiram treatment of alcoholism: A Veterans Administration Cooperative Study. Journal of the American Medical Association 256:1449-1489, 1986.
8. GRANT, B.F.; HARFORD, T.C.; DAWSON, D.A.; CHOU, P.; DUFOUR, M.; AND PICKERING, R. Prevalence of DSM-IV alcohol abuse and dependence: United States, 1992. Alcohol Health & Research World 18(3):243-248, 1994.
9. HAYASHIDA, M. An overview of outpatient and inpatient detoxification. Alcohol Health & Research World 22(1):44-46, 1998.
10. HAYASHIDA, M.; ALTERMAN, A.I.; MCLELLAN, A.T.; O'BRIEN, C.P.; PURTILL, J.J.; VOLPICELLI, J.R.; RAPHAELSON, A.H.; AND HALL, C.P. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. New England Journal of Medicine 320(6):358-364, 1989.
11. HUMPHREYS, K.; MANKOWSKI, E.S.; MOSS, R.H.; AND FINNEY, J.W. Do enhanced friendship networks and active coping mediate the effect of self-help groups on substance abuse? Annals of Behavioral Medicine, in press.
12. ISRAEL, Y.; HOLLANDER, O.; SANCHEZ-CRAIG, M.; BOOKER, S.; MILLER, V.; GINGRICH, R.; AND RANKIN, J.G. Screening for problem drinking and counseling by the primary care physician-nurse team. Alcoholism: Clinical and Experimental Research 20:1443-1450, 1996.
13. JOHNSON, B.A.; JASINSKI, D.R.; GALLOWAY, G.P.; KRANZLER, H.; WEINREIB, R.; ANTON, R.F.; MASON, B.J.; BOHN, M.J.; PETTANATI, H.M.; RAWSON, R.; CLYDE, C.; AND Ritanserin Study Group. Ritanserin in the treatment of alcohol dependence - A multicenter clinical trial. Psychopharmacology 128:206-215, 1996.
14. KAIM, S.C.; KLETT, C.J.; AND POTHFELD, B. Treatment of the acute alcohol withdrawal state: A comparison of four drugs. American Journal of Psychiatry 125:1640-1646, 1969.
15. KRANZLER, H.R.; BURLESON, JA; DEL BOCA, F.K.; BABOR, T.F.; KORNER, P.; BROWN, J.; AND BOHN, M.J. Buspirone treatment of anxious alcoholics: A placebo-controlled trial. Archives of General Psychiatry 51:720-731, 1994.
16. KRANZLER, H.R.; BURLESON, JA; KORNER, P.; DEL BOCA, F.K.; BOHN, M.J.; BROWN, J.; AND LIEBOWITZ, N. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. American Journal of Psychiatry 152:391-397, 1995.
17. LONGABAUGH, R.; WIRTZ, P.W.; ZWEBEN, A.; AND STOUT, R.L. Network support for drinking: Alcoholics Anonymous and long term matching effects. Addiction 93:1313-1333, 1998.
18. MALCOLM, R.; ANTON, R.F.; RANDALL, C.L.; JOHNSTON, A.; BRADY, K.; AND THEVOS, A. A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcoholism: Clinical and Experimental Research 16:1007-1013, 1992.
19. MASON, B.J.; KOCSIS, J.H.; RITVO, E.C.; AND CUTLER, R.B. A double-blind placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. Journal of the American Medical Association 275:761-767, 1996.
20. MCCRADY, B.S. Alcoholics Anonymous and behavior therapy: Can habits be treated as diseases? Can diseases be treated as habits? Journal of Consulting and Clinical Psychology 62:1159-1166, 1994.
21. MCGRATH, P.J.; NUNES, E.V.; STEWART, J.W.; GOLDMAN, D.; AGOSTI, V.; OCEPCK-WELIKSON, K.; AND QUITKIN, F.M. Imipramine treatment of alcoholics with major depression: A placebo-controlled clinical trial. Archives of General Psychiatry 53:232-240, 1996.
22. National Institute on Alcohol Abuse and Alcoholism. Ninth Special Report to the U.S. Congress on Alcohol and Health. Washington, DC: U.S. Department of Health and Human Services, 1997.
23. O'MALLEY, S.S.; JAFFE, A.J.; CHANG, G.; SCHOTTENFELD, R.S.; MEYER, R.E.; AND ROUNSAVILLE, B. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry 49(11):881-887, 1992.
24. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol 58:7-29, 1997a.
25. Project MATCH Research Group. Project MATCH secondary a priori hypotheses. Addiction 92:1671-1698, 1997b.
26. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research 22:1300-1311, 1998a.
27. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Treatment main effects and matching effects on drinking during treatment. Journal of Studies on Alcohol 59: 631-639, 1998b.
28. SAITZ, R. Introduction to alcohol withdrawal. Alcohol Health & Research World 22(1):5-12, 1998.
29. SASS, H.; SOYKA, M.; MANN, K.; AND ZIEGLGANSBERGER, W. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Archives of General Psychiatry 53:673-680, 1996.
30. SULLIVAN, J.T.; SYKORA, K.; SCHNEIDERMAN, J.; NARANJO, C.A.; AND SELLERS, E.M. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). British Journal of Addiction 84:1353-1357, 1989.
31. VOLPICELLI, J.R.; ALTERMAN, A.I.; HAYASHIDA, M.; AND O'BRIEN, C.P. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49(11):876-880, 1992.
32. VOLPICELLI, J.R.; RHINES, K.C.; RHINES, J.S.; VOLPICELLI, L.A.; ALTERMAN, A.I.; AND O'BRIEN, C.P. Naltrexone and alcohol dependence. Role of subject compliance. Archives of General Psychiatry 54:737-742, 1997.
33. WALSH, D.C.; HINGSON, R.W.; MERRIGAN, D.M.; LEVENSON, S.M.; CUPPLES, L.A.; HEEREN, T.; COFFMAN, G.A.; BECKER, C.A.; BARKER, T.A.; HAMILTON, A.K.; MCGUIRE, T.G.; AND KELLY, C.A. A randomized trial of treatment options for alcohol-abusing workers. New England Journal of Medicine 325(11):775-782, 1991.